Thrombogenicity of a New Injectable Biocompatible Elastomer for Aneurysm Exclusion, Compared to Expanded Polytetrafluoroethylene in a Human Ex Vivo Model
T.J. van der Steenhoven(Elisabeth-TweeSteden Ziekenhuis), Jan M.M. Heyligers(Elisabeth-TweeSteden Ziekenhuis), Frans L. Moll(Metallco (Norway)), Willem-Maarten Bosman(Leiden University Medical Center), Michael J. Jacobs(RWTH Aachen University), Philip G. de Groot(Synapse (Netherlands)), Claudia Tersteeg(University Medical Center Utrecht)
Cited by 12
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Editor's Choice – Management of Descending Thoracic Aorta Diseases
|European Journal of Vascular and Endovascular Surgery|2017|1.2k
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study
|The Lancet Neurology|2009|428